Founders Financial Alliance’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,383
| Closed | -$209K | – | 572 |
|
|
2025
Q1 | $209K | Sell |
5,383
-614
| -10% | -$23.8K | 0.05% | 334 |
|
|
2024
Q4 | $203K | Sell |
5,997
-42
| -0.7% | -$1.42K | 0.06% | 275 |
|
|
2024
Q3 | $247K | Buy |
6,039
+1
| +0% | +$41 | 0.07% | 250 |
|
|
2024
Q2 | $232K | Hold |
6,038
| – | – | 0.07% | 248 |
|
|
2024
Q1 | $259K | Sell |
6,038
-2,221
| -27% | -$95.2K | 0.08% | 222 |
|
|
2023
Q4 | $306K | Sell |
8,259
-360
| -4% | -$13.3K | 0.12% | 181 |
|
|
2023
Q3 | $312K | Sell |
8,619
-679
| -7% | -$24.6K | 0.14% | 162 |
|
|
2023
Q2 | $331K | Buy |
9,298
+2,501
| +37% | +$89.1K | 0.13% | 168 |
|
|
2023
Q1 | $244K | Sell |
6,797
-2,401
| -26% | -$86.1K | 0.12% | 176 |
|
|
2022
Q4 | $323K | Sell |
9,198
-68
| -0.7% | -$2.39K | 0.15% | 151 |
|
|
2022
Q3 | $273K | Buy |
9,266
+4,925
| +113% | +$145K | 0.14% | 162 |
|
|
2022
Q2 | $236K | Sell |
4,341
-1,291
| -23% | -$70.2K | 0.12% | 186 |
|
|
2022
Q1 | $307K | Hold |
5,632
| – | – | 0.14% | 155 |
|
|
2021
Q4 | $310K | Buy |
5,632
+1
| +0% | +$55 | 0.12% | 178 |
|
|
2021
Q3 | $268K | Hold |
5,631
| – | – | 0.13% | 172 |
|
|
2021
Q2 | $279K | Hold |
5,631
| – | – | 0.13% | 185 |
|
|
2021
Q1 | $266K | Buy |
5,631
+245
| +5% | +$11.6K | 0.13% | 178 |
|
|
2020
Q4 | $246K | Buy |
5,386
+440
| +9% | +$20.1K | 0.14% | 163 |
|
|
2020
Q3 | $230K | Buy |
+4,946
| New | +$230K | 0.14% | 139 |
|